- -

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by


  • Estadisticas de Uso

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Show full item record

Cuadrado, A.; Manda, G.; Hassan, A.; Alcaraz Tormo, MJ.; Barbas, C.; Daiber, A.; Ghezzi, P.... (2018). Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacological Reviews. 70(2):348-383. https://doi.org/10.1124/pr.117.014753

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/148465

Files in this item

Item Metadata

Title: Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Author: Cuadrado, Antonio Manda, Gina Hassan, Ahmed ALCARAZ TORMO, Mª JOSE Barbas, Coral Daiber, Andreas Ghezzi, Pietro León, Rafael Lopez, Manuela G. Oliva, Baldo Pajares, Marta Rojo, Ana I. Robledinos-Antón, Natalia Valverde, Ángela M. Guney, Emre
Issued date:
Copyrigths: Cerrado
Pharmacological Reviews. (issn: 0031-6997 )
DOI: 10.1124/pr.117.014753
American Society for Pharmacology & Experimental Therapeutics
Publisher version: https://doi.org/10.1124/pr.117.014753
Project ID:
info:eu-repo/grantAgreement/EC/FP7/294683/EU/Radical Medicine: Redefining Oxidative Stress/RADMED/
info:eu-repo/grantAgreement/COST//CA15120/EU/Open Multiscale Systems Medicine (OpenMultiMed)/
info:eu-repo/grantAgreement/MINECO//PI14%2F00372/ES/Compuestos muldidiana quirales para el tratamiento de enfermedades neurodegenerativas: ligandos de receptores nicotínicos, inductores de Nrf2 y anti-inflamatorios/
info:eu-repo/grantAgreement/GVA//PROMETEOII%2F2014%2F071/ES/Estrategias de protección frente a procesos inflamatorios y degenerativos/
This work was supported by Grants SAF2015-71304-REDT, SAF2016-76520-R, SAF2013-4874R, SAF2015-65267-R, and BIO2014-57518 of the Spanish Ministry of Economy and Competiveness; PII4/00372 from the Health Institute Carlos ...[+]
Type: Artículo


Abdanipour, A., Tiraihi, T., Noori-Zadeh, A., Majdi, A., & Gosaili, R. (2014). Evaluation of Lovastatin Effects on Expression of Anti-apoptotic Nrf2 and PGC-1α Genes in Neural Stem Cells Treated with Hydrogen Peroxide. Molecular Neurobiology, 49(3), 1364-1372. doi:10.1007/s12035-013-8613-5

Abed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015). Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica B, 5(4), 285-299. doi:10.1016/j.apsb.2015.05.008

Aleksunes, L. M. (2006). Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World Journal of Gastroenterology, 12(12), 1937. doi:10.3748/wjg.v12.i12.1937 [+]
Abdanipour, A., Tiraihi, T., Noori-Zadeh, A., Majdi, A., & Gosaili, R. (2014). Evaluation of Lovastatin Effects on Expression of Anti-apoptotic Nrf2 and PGC-1α Genes in Neural Stem Cells Treated with Hydrogen Peroxide. Molecular Neurobiology, 49(3), 1364-1372. doi:10.1007/s12035-013-8613-5

Abed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015). Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica B, 5(4), 285-299. doi:10.1016/j.apsb.2015.05.008

Aleksunes, L. M. (2006). Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World Journal of Gastroenterology, 12(12), 1937. doi:10.3748/wjg.v12.i12.1937

Aleksunes, L. M., & Manautou, J. E. (2007). Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease. Toxicologic Pathology, 35(4), 459-473. doi:10.1080/01926230701311344

Al-Huseini, L. M. A., Aw Yeang, H. X., Sethu, S., Alhumeed, N., Hamdam, J. M., Tingle, Y., … Sathish, J. G. (2013). Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling. Journal of Biological Chemistry, 288(31), 22281-22288. doi:10.1074/jbc.m113.483420

Al-Jaderi, Z., & Maghazachi, A. (2015). Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis. Toxins, 7(11), 4730-4744. doi:10.3390/toxins7114730

Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., … Joshi, R. K. (1994). Antipsoriatic effect of fumaric acid derivatives. Journal of the American Academy of Dermatology, 30(6), 977-981. doi:10.1016/s0190-9622(94)70121-0

Archer, E., Pavela, G., & Lavie, C. J. (2015). The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity Research and the Scientific Formulation of National Dietary Guidelines. Mayo Clinic Proceedings, 90(7), 911-926. doi:10.1016/j.mayocp.2015.04.009

Arlt, A., Sebens, S., Krebs, S., Geismann, C., Grossmann, M., Kruse, M.-L., … Schäfer, H. (2012). Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene, 32(40), 4825-4835. doi:10.1038/onc.2012.493

Artaud-Macari, E., Goven, D., Brayer, S., Hamimi, A., Besnard, V., Marchal-Somme, J., … Bonay, M. (2013). Nuclear Factor Erythroid 2-Related Factor 2 Nuclear Translocation Induces Myofibroblastic Dedifferentiation in Idiopathic Pulmonary Fibrosis. Antioxidants & Redox Signaling, 18(1), 66-79. doi:10.1089/ars.2011.4240

Ashabi, G., Khalaj, L., Khodagholi, F., Goudarzvand, M., & Sarkaki, A. (2014). Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metabolic Brain Disease, 30(3), 747-754. doi:10.1007/s11011-014-9632-2

Attucks, O. C., Jasmer, K. J., Hannink, M., Kassis, J., Zhong, Z., Gupta, S., … Kostura, M. J. (2014). Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity. PLoS ONE, 9(7), e101044. doi:10.1371/journal.pone.0101044

Aviello, G., & Knaus, U. (2016). ROS in gastrointestinal inflammation: Rescue Or Sabotage? British Journal of Pharmacology, 174(12), 1704-1718. doi:10.1111/bph.13428

Bonsignori, M., Kreider, E. F., Fera, D., Meyerhoff, R. R., Bradley, T., Wiehe, K., … Haynes, B. F. (2017). Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies. Science Translational Medicine, 9(381), eaai7514. doi:10.1126/scitranslmed.aai7514

Bahadoran, Z., Mirmiran, P., Hosseinpanah, F., Rajab, A., Asghari, G., & Azizi, F. (2012). Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Diabetes Research and Clinical Practice, 96(3), 348-354. doi:10.1016/j.diabres.2012.01.009

Baillie, J. K., Arner, E., Daub, C., De Hoon, M., Itoh, M., … Kawaji, H. (2017). Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease. PLOS Genetics, 13(3), e1006641. doi:10.1371/journal.pgen.1006641

Baird, L., & Dinkova-Kostova, A. T. (2013). Diffusion dynamics of the Keap1–Cullin3 interaction in single live cells. Biochemical and Biophysical Research Communications, 433(1), 58-65. doi:10.1016/j.bbrc.2013.02.065

Banning, A., & Brigelius-Flohé, R. (2005). NF-κB, Nrf2, and HO-1 Interplay in Redox-Regulated VCAM-1 Expression. Antioxidants & Redox Signaling, 7(7-8), 889-899. doi:10.1089/ars.2005.7.889

Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2010). Network medicine: a network-based approach to human disease. Nature Reviews Genetics, 12(1), 56-68. doi:10.1038/nrg2918

Batthyany CI Lopez GV (2015) Nitroalkene Tocopherols and Analogs Thereof for Use in the Treatment and Prevention of Inflammation Related Conditions, Complexa, Radnor, PA.

Bauer, P. V., & Duca, F. A. (2016). Targeting the gastrointestinal tract to treat type 2 diabetes. Journal of Endocrinology, 230(3), R95-R113. doi:10.1530/joe-16-0056

Bergström, P., von Otter, M., Nilsson, S., Nilsson, A.-C., Nilsson, M., Andersen, P. M., … Zetterberg, H. (2013). Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(1-2), 130-137. doi:10.3109/21678421.2013.839708

Bertrand, H. C., Schaap, M., Baird, L., Georgakopoulos, N. D., Fowkes, A., Thiollier, C., … Wells, G. (2015). Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1–Nrf2 Protein–Protein Interaction. Journal of Medicinal Chemistry, 58(18), 7186-7194. doi:10.1021/acs.jmedchem.5b00602

Beurel, E., Grieco, S. F., & Jope, R. S. (2015). Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacology & Therapeutics, 148, 114-131. doi:10.1016/j.pharmthera.2014.11.016

Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012). Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research, 32(7), 537-541. doi:10.1016/j.nutres.2012.06.003

Blewett, M. M., Xie, J., Zaro, B. W., Backus, K. M., Altman, A., Teijaro, J. R., & Cravatt, B. F. (2016). Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells. Science Signaling, 9(445), rs10-rs10. doi:10.1126/scisignal.aaf7694

Bolaños, J. P. (2016). Bioenergetics and redox adaptations of astrocytes to neuronal activity. Journal of Neurochemistry, 139(S2), 115-125. doi:10.1111/jnc.13486

Bourdonnay, E., Morzadec, C., Fardel, O., & Vernhet, L. (2009). Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic. Journal of Cellular Biochemistry, 107(3), 537-547. doi:10.1002/jcb.22155

Bowie, A., & O’Neill, L. A. . (2000). Oxidative stress and nuclear factor-κB activation. Biochemical Pharmacology, 59(1), 13-23. doi:10.1016/s0006-2952(99)00296-8

Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., … Wittmann, I. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. British Journal of Nutrition, 106(3), 383-389. doi:10.1017/s0007114511000316

Brennan, M. S., Matos, M. F., Richter, K. E., Li, B., & Scannevin, R. H. (2017). The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes. Scientific Reports, 7(1). doi:10.1038/srep42054

Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., … Weigert, A. (2013). Redox Control of Inflammation in Macrophages. Antioxidants & Redox Signaling, 19(6), 595-637. doi:10.1089/ars.2012.4785

Buendia, I., Gómez-Rangel, V., González-Lafuente, L., Parada, E., León, R., Gameiro, I., … López, M. G. (2015). Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models. Neuropharmacology, 99, 187-195. doi:10.1016/j.neuropharm.2015.07.014

Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016). Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacology & Therapeutics, 157, 84-104. doi:10.1016/j.pharmthera.2015.11.003

Buendia, I., Navarro, E., Michalska, P., Gameiro, I., Egea, J., Abril, S., … León, R. (2015). New melatonin–cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection. Future Medicinal Chemistry, 7(15), 1961-1969. doi:10.4155/fmc.15.99

Cajaraville, M. P., Bebianno, M. J., Blasco, J., Porte, C., Sarasquete, C., & Viarengo, A. (2000). The use of biomarkers to assess the impact of pollution in coastal environments of the Iberian Peninsula: a practical approach. Science of The Total Environment, 247(2-3), 295-311. doi:10.1016/s0048-9697(99)00499-4

Cazanave, S. C., Wang, X., Zhou, H., Rahmani, M., Grant, S., Durrant, D. E., … Sanyal, A. J. (2014). Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death & Differentiation, 21(8), 1303-1312. doi:10.1038/cdd.2014.49

Cescon, D. W., She, D., Sakashita, S., Zhu, C.-Q., Pintilie, M., Shepherd, F. A., & Tsao, M.-S. (2015). NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma. Clinical Cancer Research, 21(11), 2499-2505. doi:10.1158/1078-0432.ccr-14-2206

Chen, H., Assmann, J. C., Krenz, A., Rahman, M., Grimm, M., Karsten, C. M., … Schwaninger, M. (2014). Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE. Journal of Clinical Investigation, 124(5), 2188-2192. doi:10.1172/jci72151

Chen, J., Yu, Y., Ji, T., Ma, R., Chen, M., Li, G., … Cai, X. (2016). Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma. Cancer Medicine, 5(10), 2678-2687. doi:10.1002/cam4.788

Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009). Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response. Molecular Cell, 34(6), 663-673. doi:10.1016/j.molcel.2009.04.029

Chen, Y., Inoyama, D., Kong, A.-N. T., Beamer, L. J., & Hu, L. (2011). Kinetic Analyses of Keap1-Nrf2 Interaction and Determination of the Minimal Nrf2 Peptide Sequence Required for Keap1 Binding Using Surface Plasmon Resonance. Chemical Biology & Drug Design, 78(6), 1014-1021. doi:10.1111/j.1747-0285.2011.01240.x

Chen, Y.-C., Wu, Y.-R., Wu, Y.-C., Lee-Chen, G.-J., & Chen, C.-M. (2013). Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson’s disease. Parkinsonism & Related Disorders, 19(2), 247-250. doi:10.1016/j.parkreldis.2012.10.018

Chin, M. P., Reisman, S. A., Bakris, G. L., O’Grady, M., Linde, P. G., McCullough, P. A., … Meyer, C. J. (2014). Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl. American Journal of Nephrology, 39(6), 499-508. doi:10.1159/000362906

Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013). Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder. Pharmacological Reviews, 65(1), 105-142. doi:10.1124/pr.111.005512

Cho, H.-Y., & Kleeberger, S. R. (2010). Nrf2 protects against airway disorders. Toxicology and Applied Pharmacology, 244(1), 43-56. doi:10.1016/j.taap.2009.07.024

Cho, H.-Y., Marzec, J., & Kleeberger, S. R. (2015). Functional polymorphisms in Nrf2: implications for human disease. Free Radical Biology and Medicine, 88, 362-372. doi:10.1016/j.freeradbiomed.2015.06.012

Cho, H.-Y., Reddy, S. P. M., Yamamoto, M., & Kleeberger, S. R. (2004). The transcription factor NRF2 protects against pulmonary fibrosis. The FASEB Journal, 18(11), 1258-1260. doi:10.1096/fj.03-1127fje

Cho, Y.-E., Moon, P.-G., Lee, J.-E., Singh, T. S. K., Kang, W., Lee, H.-C., … Baek, M.-C. (2013). Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity. PROTEOMICS, 13(8), 1257-1275. doi:10.1002/pmic.201200368

Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2012). Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene, 32(32), 3765-3781. doi:10.1038/onc.2012.388

Christou, H., Morita, T., Hsieh, C.-M., Koike, H., Arkonac, B., Perrella, M. A., & Kourembanas, S. (2000). Prevention of Hypoxia-Induced Pulmonary Hypertension by Enhancement of Endogenous Heme Oxygenase-1 in the Rat. Circulation Research, 86(12), 1224-1229. doi:10.1161/01.res.86.12.1224

Chuengsamarn, S., Rattanamongkolgul, S., Phonrat, B., Tungtrongchitr, R., & Jirawatnotai, S. (2014). Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. The Journal of Nutritional Biochemistry, 25(2), 144-150. doi:10.1016/j.jnutbio.2013.09.013

Ci, X., Zhou, J., Lv, H., Yu, Q., Peng, L., & Hua, S. (2017). Betulin exhibits anti-inflammatory activity in LPS-stimulated macrophages and endotoxin-shocked mice through an AMPK/AKT/Nrf2-dependent mechanism. Cell Death & Disease, 8(5), e2798-e2798. doi:10.1038/cddis.2017.39

Cleasby, A., Yon, J., Day, P. J., Richardson, C., Tickle, I. J., Williams, P. A., … Davies, T. G. (2014). Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO. PLoS ONE, 9(6), e98896. doi:10.1371/journal.pone.0098896

Comandini, A., Marzano, V., Curradi, G., Federici, G., Urbani, A., & Saltini, C. (2010). Markers of anti-oxidant response in tobacco smoke exposed subjects: A data-mining review. Pulmonary Pharmacology & Therapeutics, 23(6), 482-492. doi:10.1016/j.pupt.2010.05.006

Córdova, E., Velázquez-Cruz, R., Centeno, F., Baca, V., & Orozco, L. (2010). The NRF2 gene variant, -653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus. Lupus, 19(10), 1237-1242. doi:10.1177/0961203310367917

Croze, E., Yamaguchi, K. D., Knappertz, V., Reder, A. T., & Salamon, H. (2012). Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. The Pharmacogenomics Journal, 13(5), 443-451. doi:10.1038/tpj.2012.27

Cuadrado, A. (2015). Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP. Free Radical Biology and Medicine, 88, 147-157. doi:10.1016/j.freeradbiomed.2015.04.029

Cuadrado, A., Martín-Moldes, Z., Ye, J., & Lastres-Becker, I. (2014). Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation. Journal of Biological Chemistry, 289(22), 15244-15258. doi:10.1074/jbc.m113.540633

Cuadrado, A., Moreno-Murciano, P., & Pedraza-Chaverri, J. (2009). The transcription factor Nrf2 as a new therapeutic target in Parkinson’s disease. Expert Opinion on Therapeutic Targets, 13(3), 319-329. doi:10.1517/13543780802716501

Cui, Y., Wang, Q., Li, X., & Zhang, X. (2013). Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. Redox Biology, 1(1), 433-440. doi:10.1016/j.redox.2013.08.003

Datta, S., Kundu, S., Ghosh, P., De, S., Ghosh, A., & Chatterjee, M. (2014). Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clinical Rheumatology, 33(11), 1557-1564. doi:10.1007/s10067-014-2597-z

De la Vega, M. R., Dodson, M., Gross, C., Mansour, H. M., Lantz, R. C., Chapman, E., … Zhang, D. D. (2016). Role of Nrf2 and Autophagy in Acute Lung Injury. Current Pharmacology Reports, 2(2), 91-101. doi:10.1007/s40495-016-0053-2

DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., … Tuveson, D. A. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature, 475(7354), 106-109. doi:10.1038/nature10189

De Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., … Chertow, G. M. (2013). Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease. New England Journal of Medicine, 369(26), 2492-2503. doi:10.1056/nejmoa1306033

Diotallevi, M., Checconi, P., Palamara, A. T., Celestino, I., Coppo, L., Holmgren, A., … Ghezzi, P. (2017). Glutathione Fine-Tunes the Innate Immune Response toward Antiviral Pathways in a Macrophage Cell Line Independently of Its Antioxidant Properties. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.01239

Duran, C. G., Burbank, A. J., Mills, K. H., Duckworth, H. R., Aleman, M. M., Kesic, M. J., … Hernandez, M. L. (2016). A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation. Respiratory Research, 17(1). doi:10.1186/s12931-016-0406-8

Eades, G., Yang, M., Yao, Y., Zhang, Y., & Zhou, Q. (2011). miR-200a Regulates Nrf2 Activation by TargetingKeap1mRNA in Breast Cancer Cells. Journal of Biological Chemistry, 286(47), 40725-40733. doi:10.1074/jbc.m111.275495

Egea, J., Buendia, I., Parada, E., Navarro, E., Rada, P., Cuadrado, A., … León, R. (2015). Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a ‘drug-prodrug’ mechanism of action. British Journal of Pharmacology, 172(7), 1807-1821. doi:10.1111/bph.13025

Ellrichmann, G., Petrasch-Parwez, E., Lee, D.-H., Reick, C., Arning, L., Saft, C., … Linker, R. A. (2011). Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington’s Disease. PLoS ONE, 6(1), e16172. doi:10.1371/journal.pone.0016172

El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000). Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I. Journal of Biological Chemistry, 275(1), 223-228. doi:10.1074/jbc.275.1.223

Eminel, S., Jin, N., Rostami, M., Dibbert, S., Mrowietz, U., & Suhrkamp, I. (2016). Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells. Experimental Dermatology, 26(8), 685-690. doi:10.1111/exd.13138

Emmink, B. L., Verheem, A., Van Houdt, W. J., Steller, E. J. A., Govaert, K. M., Pham, T. V., … Kranenburg, O. (2013). The secretome of colon cancer stem cells contains drug-metabolizing enzymes. Journal of Proteomics, 91, 84-96. doi:10.1016/j.jprot.2013.06.027

Evans, M. D., Cooke, M. S., Akil, M., Samanta, A., & Lunec, J. (2000). Aberrant Processing of Oxidative DNA Damage in Systemic Lupus Erythematosus. Biochemical and Biophysical Research Communications, 273(3), 894-898. doi:10.1006/bbrc.2000.3078

Fagone, P., Patti, F., Mangano, K., Mammana, S., Coco, M., Touil-Boukoffa, C., … Nicoletti, F. (2013). Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis. Journal of Neuroimmunology, 261(1-2), 82-86. doi:10.1016/j.jneuroim.2013.04.013

Finkelstein, R., Fraser, R. S., Ghezzo, H., & Cosio, M. G. (1995). Alveolar inflammation and its relation to emphysema in smokers. American Journal of Respiratory and Critical Care Medicine, 152(5), 1666-1672. doi:10.1164/ajrccm.152.5.7582312

Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdova, E., Kita, M., … Dawson, K. T. (2012). Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis. New England Journal of Medicine, 367(12), 1087-1097. doi:10.1056/nejmoa1206328

Freitas, A. E., Egea, J., Buendia, I., Gómez-Rangel, V., Parada, E., Navarro, E., … Lopez, M. G. (2015). Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice. Molecular Neurobiology, 53(5), 3030-3045. doi:10.1007/s12035-015-9182-6

Frijhoff, J., Winyard, P. G., Zarkovic, N., Davies, S. S., Stocker, R., Cheng, D., … Ghezzi, P. (2015). Clinical Relevance of Biomarkers of Oxidative Stress. Antioxidants & Redox Signaling, 23(14), 1144-1170. doi:10.1089/ars.2015.6317

Frostegård, J., Svenungsson, E., Wu, R., Gunnarsson, I., Lundberg, I. E., Klareskog, L., … Witztum, J. L. (2005). Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis & Rheumatism, 52(1), 192-200. doi:10.1002/art.20780

Gao, J., Chang, M. T., Johnsen, H. C., Gao, S. P., Sylvester, B. E., Sumer, S. O., … Sander, C. (2017). 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets. Genome Medicine, 9(1). doi:10.1186/s13073-016-0393-x

Ghanim, H., Sia, C. L., Korzeniewski, K., Lohano, T., Abuaysheh, S., Marumganti, A., … Dandona, P. (2011). A Resveratrol and Polyphenol Preparation Suppresses Oxidative and Inflammatory Stress Response to a High-Fat, High-Carbohydrate Meal. The Journal of Clinical Endocrinology & Metabolism, 96(5), 1409-1414. doi:10.1210/jc.2010-1812

Ghezzi P Floridi L Boraschi D Cuadrado A Manda G Levic S D’Acquisto F Hamilton A Athersuch TJ Selley L (2017 a) Oxidative stress and inflammation induced by environmental and psychological stressors: a biomarker perspective. Antioxid Redox Signal [published ahead of print].

Ghezzi, P., Jaquet, V., Marcucci, F., & Schmidt, H. H. H. W. (2016). The oxidative stress theory of disease: levels of evidence and epistemological aspects. British Journal of Pharmacology, 174(12), 1784-1796. doi:10.1111/bph.13544

Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O., … Röcken, M. (2011). Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. Journal of Experimental Medicine, 208(11), 2291-2303. doi:10.1084/jem.20100977

Gillard, G. O., Collette, B., Anderson, J., Chao, J., Scannevin, R. H., Huss, D. J., & Fontenot, J. D. (2015). DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner. Journal of Neuroimmunology, 283, 74-85. doi:10.1016/j.jneuroim.2015.04.006

Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabasi, A.-L. (2007). The human disease network. Proceedings of the National Academy of Sciences, 104(21), 8685-8690. doi:10.1073/pnas.0701361104

Gold, R., Kappos, L., Arnold, D. L., Bar-Or, A., Giovannoni, G., Selmaj, K., … Dawson, K. T. (2012). Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. New England Journal of Medicine, 367(12), 1098-1107. doi:10.1056/nejmoa1114287

Gonzalez-Donquiles, C., Alonso-Molero, J., Fernandez-Villa, T., Vilorio-Marqués, L., Molina, A. J., & Martín, V. (2017). The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review. PLOS ONE, 12(5), e0177549. doi:10.1371/journal.pone.0177549

Goven, D., Boutten, A., Lecon-Malas, V., Marchal-Somme, J., Amara, N., Crestani, B., … Bonay, M. (2008). Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax, 63(10), 916-924. doi:10.1136/thx.2007.091181

Griendling, K. K., & FitzGerald, G. A. (2003). Oxidative Stress and Cardiovascular Injury. Circulation, 108(16), 1912-1916. doi:10.1161/01.cir.0000093660.86242.bb

Griendling, K. K., & FitzGerald, G. A. (2003). Oxidative Stress and Cardiovascular Injury. Circulation, 108(17), 2034-2040. doi:10.1161/01.cir.0000093661.90582.c4

Guan, C.-P., Zhou, M.-N., Xu, A.-E., Kang, K.-F., Liu, J.-F., Wei, X.-D., … Hong, W.-S. (2008). The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population. Experimental Dermatology, 17(12), 1059-1062. doi:10.1111/j.1600-0625.2008.00752.x

Guney, E., Menche, J., Vidal, M., & Barábasi, A.-L. (2016). Network-based in silico drug efficacy screening. Nature Communications, 7(1). doi:10.1038/ncomms10331

Guney, E., & Oliva, B. (2014). Analysis of the Robustness of Network-Based Disease-Gene Prioritization Methods Reveals Redundancy in the Human Interactome and Functional Diversity of Disease-Genes. PLoS ONE, 9(4), e94686. doi:10.1371/journal.pone.0094686

Han, S.-J., Ahn, Y., Park, I., Zhang, Y., Kim, I., Kim, H. W., … Lee, S.-R. (2015). Assay of the redox state of the tumor suppressor PTEN by mobility shift. Methods, 77-78, 58-62. doi:10.1016/j.ymeth.2015.01.007

Hancock, R., Schaap, M., Pfister, H., & Wells, G. (2013). Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction with improved binding and cellular activity. Organic & Biomolecular Chemistry, 11(21), 3553. doi:10.1039/c3ob40249e

Harder, B., Tian, W., La Clair, J. J., Tan, A.-C., Ooi, A., Chapman, E., & Zhang, D. D. (2017). Brusatol overcomes chemoresistance through inhibition of protein translation. Molecular Carcinogenesis, 56(5), 1493-1500. doi:10.1002/mc.22609

Hardie, D. G. (2004). The AMP-activated protein kinase pathway - new players upstream and downstream. Journal of Cell Science, 117(23), 5479-5487. doi:10.1242/jcs.01540

Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003). Role of oxidative stress in atherosclerosis. The American Journal of Cardiology, 91(3), 7-11. doi:10.1016/s0002-9149(02)03144-2

Hart, P. C., Ratti, B. A., Mao, M., Ansenberger-Fricano, K., Shajahan-Haq, A. N., Tyner, A. L., … Bonini, M. G. (2015). Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis. Oncotarget, 7(1), 308-322. doi:10.18632/oncotarget.5687

Harvey, C. J., Thimmulappa, R. K., Sethi, S., Kong, X., Yarmus, L., Brown, R. H., … Biswal, S. (2011). Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model. Science Translational Medicine, 3(78), 78ra32-78ra32. doi:10.1126/scitranslmed.3002042

Hast, B. E., Goldfarb, D., Mulvaney, K. M., Hast, M. A., Siesser, P. F., Yan, F., … Major, M. B. (2013). Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination. Cancer Research, 73(7), 2199-2210. doi:10.1158/0008-5472.can-12-4400

Hayes, J. D., & Dinkova-Kostova, A. T. (2014). The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends in Biochemical Sciences, 39(4), 199-218. doi:10.1016/j.tibs.2014.02.002

Heckman-Stoddard, B. M., DeCensi, A., Sahasrabuddhe, V. V., & Ford, L. G. (2017). Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia, 60(9), 1639-1647. doi:10.1007/s00125-017-4372-6

Hidalgo, C. A., Blumm, N., Barabási, A.-L., & Christakis, N. A. (2009). A Dynamic Network Approach for the Study of Human Phenotypes. PLoS Computational Biology, 5(4), e1000353. doi:10.1371/journal.pcbi.1000353

Hong, D. S., Kurzrock, R., Supko, J. G., He, X., Naing, A., Wheler, J., … Dezube, B. J. (2012). A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas. Clinical Cancer Research, 18(12), 3396-3406. doi:10.1158/1078-0432.ccr-11-2703

Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R. (1996). Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(2), 250-255. doi:10.1161/01.atv.16.2.250

Houessinon, A., François, C., Sauzay, C., Louandre, C., Mongelard, G., Godin, C., … Galmiche, A. (2016). Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. Molecular Cancer, 15(1). doi:10.1186/s12943-016-0526-2

Houghton, C. A., Fassett, R. G., & Coombes, J. S. (2016). Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician’s Expectation Be Matched by the Reality? Oxidative Medicine and Cellular Longevity, 2016, 1-17. doi:10.1155/2016/7857186

Hu, L., Magesh, S., Chen, L., Wang, L., Lewis, T. A., Chen, Y., … Munoz, B. (2013). Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction. Bioorganic & Medicinal Chemistry Letters, 23(10), 3039-3043. doi:10.1016/j.bmcl.2013.03.013

Hua, C.-C., Chang, L.-C., Tseng, J.-C., Chu, C.-M., Liu, Y.-C., & Shieh, W.-B. (2010). Functional Haplotypes in the Promoter Region of Transcription FactorNrf2in Chronic Obstructive Pulmonary Disease. Disease Markers, 28(3), 185-193. doi:10.1155/2010/143142

Hur, W., & Gray, N. S. (2011). Small molecule modulators of antioxidant response pathway. Current Opinion in Chemical Biology, 15(1), 162-173. doi:10.1016/j.cbpa.2010.12.009

Hwang, A.-R., Han, J.-H., Lim, J. H., Kang, Y. J., & Woo, C.-H. (2017). Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells. PLOS ONE, 12(5), e0178278. doi:10.1371/journal.pone.0178278

Innamorato, N. G., Rojo, A. I., García-Yagüe, Á. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008). The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation. The Journal of Immunology, 181(1), 680-689. doi:10.4049/jimmunol.181.1.680

Inoyama, D., Chen, Y., Huang, X., Beamer, L. J., Kong, A.-N. T., & Hu, L. (2011). Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction. Journal of Biomolecular Screening, 17(4), 435-447. doi:10.1177/1087057111430124

Iorio, F., Isacchi, A., di Bernardo, D., & Brunetti-Pierri, N. (2010). Identification of small molecules enhancing autophagic function from drug network analysis. Autophagy, 6(8), 1204-1205. doi:10.4161/auto.6.8.13551

Ishii, T., & Mann, G. E. (2014). Redox status in mammalian cells and stem cells during culture in vitro: Critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biology, 2, 786-794. doi:10.1016/j.redox.2014.04.008

Jang, H. J., Hong, E. M., Kim, M., Kim, J. H., Jang, J., Park, S. W., … Lee, J. (2016). Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer. Oncotarget, 7(29), 46219-46229. doi:10.18632/oncotarget.10078

Jansen, T., Hortmann, M., Oelze, M., Opitz, B., Steven, S., Schell, R., … Daiber, A. (2010). Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1—evidence for direct and indirect antioxidant actions of bilirubin. Journal of Molecular and Cellular Cardiology, 49(2), 186-195. doi:10.1016/j.yjmcc.2010.04.011

Jay, D., Hitomi, H., & Griendling, K. K. (2006). Oxidative stress and diabetic cardiovascular complications. Free Radical Biology and Medicine, 40(2), 183-192. doi:10.1016/j.freeradbiomed.2005.06.018

Jazwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández-Ruiz, J., & Cuadrado, A. (2011). Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism. Antioxidants & Redox Signaling, 14(12), 2347-2360. doi:10.1089/ars.2010.3731

Jiang, T., Huang, Z., Lin, Y., Zhang, Z., Fang, D., & Zhang, D. D. (2010). The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy. Diabetes, 59(4), 850-860. doi:10.2337/db09-1342

Jiang, T., Tian, F., Zheng, H., Whitman, S. A., Lin, Y., Zhang, Z., … Zhang, D. D. (2014). Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response. Kidney International, 85(2), 333-343. doi:10.1038/ki.2013.343

Jiang, Z.-Y., Lu, M.-C., Xu, L., Yang, T.-T., Xi, M.-Y., Xu, X.-L., … Sun, H.-P. (2014). Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis. Journal of Medicinal Chemistry, 57(6), 2736-2745. doi:10.1021/jm5000529

Jiang, Z.-Y., Lu, M.-C., & You, Q.-D. (2016). Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions. Journal of Medicinal Chemistry, 59(24), 10837-10858. doi:10.1021/acs.jmedchem.6b00586

Jiménez-Osorio, A. S., González-Reyes, S., García-Niño, W. R., Moreno-Macías, H., Rodríguez-Arellano, M. E., Vargas-Alarcón, G., … Peralta-Leal, V. (2017). Corrigendum to «Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients». Oxidative Medicine and Cellular Longevity, 2017, 1-4. doi:10.1155/2017/7543194

Jiménez-Osorio, A., Picazo, A., González-Reyes, S., Barrera-Oviedo, D., Rodríguez-Arellano, M., & Pedraza-Chaverri, J. (2014). Nrf2 and Redox Status in Prediabetic and Diabetic Patients. International Journal of Molecular Sciences, 15(11), 20290-20305. doi:10.3390/ijms151120290

Jnoff, E., Albrecht, C., Barker, J. J., Barker, O., Beaumont, E., Bromidge, S., … Courade, J.-P. (2014). Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex. ChemMedChem, 9(4), 699-705. doi:10.1002/cmdc.201300525

Jo, C., Gundemir, S., Pritchard, S., Jin, Y. N., Rahman, I., & Johnson, G. V. W. (2014). Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nature Communications, 5(1). doi:10.1038/ncomms4496

Johnson, D. A., Amirahmadi, S., Ward, C., Fabry, Z., & Johnson, J. A. (2009). The Absence of the Pro-antioxidant Transcription Factor Nrf2 Exacerbates Experimental Autoimmune Encephalomyelitis. Toxicological Sciences, 114(2), 237-246. doi:10.1093/toxsci/kfp274

Johnson, D. A., & Johnson, J. A. (2015). Nrf2—a therapeutic target for the treatment of neurodegenerative diseases. Free Radical Biology and Medicine, 88, 253-267. doi:10.1016/j.freeradbiomed.2015.07.147

Johnson, N. M., Egner, P. A., Baxter, V. K., Sporn, M. B., Wible, R. S., Sutter, T. R., … Roebuck, B. D. (2014). Complete Protection against Aflatoxin B1-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold. Cancer Prevention Research, 7(7), 658-665. doi:10.1158/1940-6207.capr-13-0430

Jones, R. M., Desai, C., Darby, T. M., Luo, L., Wolfarth, A. A., Scharer, C. D., … Neish, A. S. (2015). Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway. Cell Reports, 12(8), 1217-1225. doi:10.1016/j.celrep.2015.07.042

Jung, K.-A., Lee, S., & Kwak, M.-K. (2017). NFE2L2/NRF2 Activity Is Linked to Mitochondria and AMP-Activated Protein Kinase Signaling in Cancers Through miR-181c/Mitochondria-Encoded Cytochrome c Oxidase Regulation. Antioxidants & Redox Signaling, 27(13), 945-961. doi:10.1089/ars.2016.6797

Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., … Thomas, B. (2013). Targeting Nrf2-Mediated Gene Transcription by Extremely Potent Synthetic Triterpenoids Attenuate Dopaminergic Neurotoxicity in the MPTP Mouse Model of Parkinson’s Disease. Antioxidants & Redox Signaling, 18(2), 139-157. doi:10.1089/ars.2011.4491

Kaisar, M. A., Villalba, H., Prasad, S., Liles, T., Sifat, A. E., Sajja, R. K., … Cucullo, L. (2017). Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure? Redox Biology, 13, 353-362. doi:10.1016/j.redox.2017.06.006

Kastrati, I., Siklos, M. I., Calderon-Gierszal, E. L., El-Shennawy, L., Georgieva, G., Thayer, E. N., … Frasor, J. (2015). Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. Journal of Biological Chemistry, 291(7), 3639-3647. doi:10.1074/jbc.m115.679704

Kelleni, M. T., Amin, E. F., & Abdelrahman, A. M. (2015). Effect of Metformin and Sitagliptin on Doxorubicin-Induced Cardiotoxicity in Rats: Impact of Oxidative Stress, Inflammation, and Apoptosis. Journal of Toxicology, 2015, 1-8. doi:10.1155/2015/424813

Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J.-G., … Talalay, P. (2012). Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane. Topics in Current Chemistry, 163-177. doi:10.1007/128_2012_339

Khan, I., Tantray, M. A., Alam, M. S., & Hamid, H. (2017). Natural and synthetic bioactive inhibitors of glycogen synthase kinase. European Journal of Medicinal Chemistry, 125, 464-477. doi:10.1016/j.ejmech.2016.09.058

Kim, J.-E., You, D.-J., Lee, C., Ahn, C., Seong, J. Y., & Hwang, J.-I. (2010). Suppression of NF-κB signaling by KEAP1 regulation of IKKβ activity through autophagic degradation and inhibition of phosphorylation. Cellular Signalling, 22(11), 1645-1654. doi:10.1016/j.cellsig.2010.06.004

Kim, T., Kim, Y.-J., Han, I.-H., Lee, D., Ham, J., Kang, K. S., & Lee, J. W. (2015). The synthesis of sulforaphane analogues and their protection effect against cisplatin induced cytotoxicity in kidney cells. Bioorganic & Medicinal Chemistry Letters, 25(1), 62-66. doi:10.1016/j.bmcl.2014.11.014

Kim, Y. R., Oh, J. E., Kim, M. S., Kang, M. R., Park, S. W., Han, J. Y., … Lee, S. H. (2009). Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. The Journal of Pathology, 220(4), 446-451. doi:10.1002/path.2653

KITAGISHI, Y., & MATSUDA, S. (2013). Redox regulation of tumor suppressor PTEN in cancer and aging. International Journal of Molecular Medicine, 31(3), 511-515. doi:10.3892/ijmm.2013.1235

Kitsak, M., Sharma, A., Menche, J., Guney, E., Ghiassian, S. D., Loscalzo, J., & Barabási, A.-L. (2016). Tissue Specificity of Human Disease Module. Scientific Reports, 6(1). doi:10.1038/srep35241

Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., … Yamamoto, M. (2016). Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nature Communications, 7(1). doi:10.1038/ncomms11624

Kocer, D., Bayram, F., & Diri, H. (2014). The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome. Gynecological Endocrinology, 30(5), 367-371. doi:10.3109/09513590.2014.887063

Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., … Yamamoto, M. (2010). The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nature Cell Biology, 12(3), 213-223. doi:10.1038/ncb2021

Kong, X., Thimmulappa, R., Craciun, F., Harvey, C., Singh, A., Kombairaju, P., … Biswal, S. (2011). Enhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against Sepsis. American Journal of Respiratory and Critical Care Medicine, 184(8), 928-938. doi:10.1164/rccm.201102-0271oc

Kruger, A. L., Peterson, S. J., Schwartzman, M. L., Fusco, H., McClung, J. A., Weiss, M., … Abraham, N. G. (2006). Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects. Journal of Pharmacology and Experimental Therapeutics, 319(3), 1144-1152. doi:10.1124/jpet.106.107482

Kruse, M.-L., Friedrich, M., Arlt, A., Röcken, C., Egberts, J.-H., Sebens, S., & Schäfer, H. (2016). Colonic Lamina Propria Inflammatory Cells from Patients with IBD Induce the Nuclear Factor-E2 Related Factor-2 Thereby Leading to Greater Proteasome Activity and Apoptosis Protection in Human Colonocytes. Inflammatory Bowel Diseases, 22(11), 2593-2606. doi:10.1097/mib.0000000000000925

Kuang, X., Scofield, V. L., Yan, M., Stoica, G., Liu, N., & Wong, P. K. Y. (2009). Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Research, 1286, 174-184. doi:10.1016/j.brainres.2009.06.007

Kurinna, S., & Werner, S. (2015). NRF2 and microRNAs: new but awaited relations. Biochemical Society Transactions, 43(4), 595-601. doi:10.1042/bst20140317

Kwak, J. Y., Takeshige, K., Cheung, B. S., & Minakami, S. (1991). Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1076(3), 369-373. doi:10.1016/0167-4838(91)90478-i

Lamb, J. (2006). The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease. Science, 313(5795), 1929-1935. doi:10.1126/science.1132939

Lastres-Becker, I., García-Yagüe, A. J., Scannevin, R. H., Casarejos, M. J., Kügler, S., Rábano, A., & Cuadrado, A. (2016). Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson’s Disease. Antioxidants & Redox Signaling, 25(2), 61-77. doi:10.1089/ars.2015.6549

Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Rábano, A., Kügler, S., Van Leuven, F., & Cuadrado, A. (2013). Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain, 137(1), 78-91. doi:10.1093/brain/awt323

Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A. (2012). α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson’s disease. Human Molecular Genetics, 21(14), 3173-3192. doi:10.1093/hmg/dds143

Lee, D., Xu, I. M.-J., Chiu, D. K.-C., Lai, R. K.-H., Tse, A. P.-W., Lan Li, L., … Wong, C. C.-L. (2017). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. Journal of Clinical Investigation, 127(5), 1856-1872. doi:10.1172/jci90253

Lee, D.-F., Kuo, H.-P., Liu, M., Chou, C.-K., Xia, W., Du, Y., … Hung, M.-C. (2009). KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ. Molecular Cell, 36(1), 131-140. doi:10.1016/j.molcel.2009.07.025

Lee, S.-R., Yang, K.-S., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002). Reversible Inactivation of the Tumor Suppressor PTEN by H2O2. Journal of Biological Chemistry, 277(23), 20336-20342. doi:10.1074/jbc.m111899200

Li, B., Cui, W., Liu, J., Li, R., Liu, Q., Xie, X.-H., … Guo, L. (2013). Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Experimental Neurology, 250, 239-249. doi:10.1016/j.expneurol.2013.10.002

Li, J., Stein, T. D., & Johnson, J. A. (2004). Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice. Physiological Genomics, 18(3), 261-272. doi:10.1152/physiolgenomics.00209.2003

Licht-Mayer, S., Wimmer, I., Traffehn, S., Metz, I., Brück, W., Bauer, J., … Lassmann, H. (2015). Cell type-specific Nrf2 expression in multiple sclerosis lesions. Acta Neuropathologica, 130(2), 263-277. doi:10.1007/s00401-015-1452-x

Limonciel, A., & Jennings, P. (2014). A Review of the Evidence that Ochratoxin A Is an Nrf2 Inhibitor: Implications for Nephrotoxicity and Renal Carcinogenicity. Toxins, 6(1), 371-379. doi:10.3390/toxins6010371

Lin, C.-H., Lin, H.-I., Chen, M.-L., Lai, T.-T., Cao, L.-P., Farrer, M. J., … Chien, C.-T. (2016). Lovastatin protects neurite degeneration inLRRK2-G2019Sparkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity. Human Molecular Genetics, 25(10), 1965-1978. doi:10.1093/hmg/ddw068

Lin, S. X., Lisi, L., Russo, C. D., Polak, P. E., Sharp, A., Weinberg, G., … Feinstein, D. L. (2011). The Anti-Inflammatory Effects of Dimethyl Fumarate in Astrocytes Involve Glutathione and Haem Oxygenase-1. ASN Neuro, 3(2), AN20100033. doi:10.1042/an20100033

Lin, W., Wu, R. T., Wu, T., Khor, T.-O., Wang, H., & Kong, A.-N. (2008). Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochemical Pharmacology, 76(8), 967-973. doi:10.1016/j.bcp.2008.07.036

Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., … Gold, R. (2011). Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain, 134(3), 678-692. doi:10.1093/brain/awq386

Liu, G.-H., Qu, J., & Shen, X. (2008). NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1783(5), 713-727. doi:10.1016/j.bbamcr.2008.01.002

Liu, T., Pei, Y., Peng, Y., Chen, J., Jiang, S., & Gong, J. (2014). Oscillating high glucose enhances oxidative stress and apoptosis in human coronary artery endothelial cells. Journal of Endocrinological Investigation, 37(7), 645-651. doi:10.1007/s40618-014-0086-5

Lo, S.-C., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006). Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. The EMBO Journal, 25(15), 3605-3617. doi:10.1038/sj.emboj.7601243

LoGerfo, A., Chico, L., Borgia, L., Petrozzi, L., Rocchi, A., D’Amelio, A., … Siciliano, G. (2014). Lack of Association between Nuclear Factor Erythroid-Derived 2-Like 2 Promoter Gene Polymorphisms and Oxidative Stress Biomarkers in Amyotrophic Lateral Sclerosis Patients. Oxidative Medicine and Cellular Longevity, 2014, 1-9. doi:10.1155/2014/432626

Lu, K., Alcivar, A. L., Ma, J., Foo, T. K., Zywea, S., Mahdi, A., … Xia, B. (2017). NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction. Cancer Research, 77(11), 2881-2892. doi:10.1158/0008-5472.can-16-2204

Lu, M.-C., Jiao, Q., Liu, T., Tan, S.-J., Zhou, H.-S., You, Q.-D., & Jiang, Z.-Y. (2018). Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency. European Journal of Medicinal Chemistry, 143, 1578-1589. doi:10.1016/j.ejmech.2017.10.052

Lv, H., Liu, Q., Wen, Z., Feng, H., Deng, X., & Ci, X. (2017). Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biology, 12, 311-324. doi:10.1016/j.redox.2017.03.001

Ma, Q. (2013). Role of Nrf2 in Oxidative Stress and Toxicity. Annual Review of Pharmacology and Toxicology, 53(1), 401-426. doi:10.1146/annurev-pharmtox-011112-140320

Ma, Q., Battelli, L., & Hubbs, A. F. (2006). Multiorgan Autoimmune Inflammation, Enhanced Lymphoproliferation, and Impaired Homeostasis of Reactive Oxygen Species in Mice Lacking the Antioxidant-Activated Transcription Factor Nrf2. The American Journal of Pathology, 168(6), 1960-1974. doi:10.2353/ajpath.2006.051113

Maicas, N., Ferrándiz, M. L., Brines, R., Ibáñez, L., Cuadrado, A., Koenders, M. I., … Alcaraz, M. J. (2011). Deficiency of Nrf2 Accelerates the Effector Phase of Arthritis and Aggravates Joint Disease. Antioxidants & Redox Signaling, 15(4), 889-901. doi:10.1089/ars.2010.3835

Manna, A., De Sarkar, S., De, S., Bauri, A. K., Chattopadhyay, S., & Chatterjee, M. (2015). The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance. Phytomedicine, 22(7-8), 713-723. doi:10.1016/j.phymed.2015.05.007

Maqbool, M., & Hoda, N. (2017). GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future. Current Pharmaceutical Design, 23(29). doi:10.2174/1381612823666170714141450

Marcotte, D., Zeng, W., Hus, J.-C., McKenzie, A., Hession, C., Jin, P., … Silvian, L. (2013). Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorganic & Medicinal Chemistry, 21(14), 4011-4019. doi:10.1016/j.bmc.2013.04.019

Markart, P., Luboeinski, T., Korfei, M., Schmidt, R., Wygrecka, M., Mahavadi, P., … Ruppert, C. (2009). Alveolar Oxidative Stress is Associated with Elevated Levels of Nonenzymatic Low-Molecular-Weight Antioxidants in Patients with Different Forms of Chronic Fibrosing Interstitial Lung Diseases. Antioxidants & Redox Signaling, 11(2), 227-240. doi:10.1089/ars.2008.2105

Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. M. (2017). Metformin – a Future Therapy for Neurodegenerative Diseases. Pharmaceutical Research, 34(12), 2614-2627. doi:10.1007/s11095-017-2199-y

Marrone, G., Maeso-Díaz, R., García-Cardena, G., Abraldes, J. G., García-Pagán, J. C., Bosch, J., & Gracia-Sancho, J. (2014). KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut, 64(9), 1434-1443. doi:10.1136/gutjnl-2014-308338

Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., … López, M. G. (2013). Nrf2 participates in depressive disorders through an anti-inflammatory mechanism. Psychoneuroendocrinology, 38(10), 2010-2022. doi:10.1016/j.psyneuen.2013.03.020

Marzec, J. M., Christie, J. D., Reddy, S. P., Jedlicka, A. E., Vuong, H., Lanken, P. N., … Kleeberger, S. R. (2007). Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. The FASEB Journal, 21(9), 2237-2246. doi:10.1096/fj.06-7759com

McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M., Abrams, S. L., … Cervello, M. (2014). GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget, 5(10), 2881-2911. doi:10.18632/oncotarget.2037

McGuire, V. A., Ruiz-Zorrilla Diez, T., Emmerich, C. H., Strickson, S., Ritorto, M. S., Sutavani, R. V., … Arthur, J. S. C. (2016). Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation. Scientific Reports, 6(1). doi:10.1038/srep31159

Meakin, P. J., Chowdhry, S., Sharma, R. S., Ashford, F. B., Walsh, S. V., McCrimmon, R. J., … Ashford, M. L. J. (2014). Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance. Molecular and Cellular Biology, 34(17), 3305-3320. doi:10.1128/mcb.00677-14

Meissner, M., Doll, M., Hrgovic, I., Reichenbach, G., König, V., Hailemariam-Jahn, T., … Kaufmann, R. (2011). Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action. Journal of Investigative Dermatology, 131(6), 1356-1364. doi:10.1038/jid.2011.46

Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabasi, A.-L. (2015). Uncovering disease-disease relationships through the incomplete interactome. Science, 347(6224), 1257601-1257601. doi:10.1126/science.1257601

Milkovic, L., Zarkovic, N., & Saso, L. (2017). Controversy about pharmacological modulation of Nrf2 for cancer therapy. Redox Biology, 12, 727-732. doi:10.1016/j.redox.2017.04.013

Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., … Motohashi, H. (2012). Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming. Cancer Cell, 22(1), 66-79. doi:10.1016/j.ccr.2012.05.016

Moon, S.-J., Park, J.-S., Woo, Y.-J., Lim, M.-A., Kim, S.-M., Lee, S.-Y., … Min, J.-K. (2014). Rebamipide Suppresses Collagen-Induced Arthritis Through Reciprocal Regulation of Th17/Treg Cell Differentiation and Heme Oxygenase 1 Induction. Arthritis & Rheumatology, 66(4), 874-885. doi:10.1002/art.38310

Morgan, M. J., & Liu, Z. (2010). Crosstalk of reactive oxygen species and NF-κB signaling. Cell Research, 21(1), 103-115. doi:10.1038/cr.2010.178

Morgan, P. E., Sturgess, A. D., Hennessy, A., & Davies, M. J. (2007). Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radical Research, 41(12), 1301-1312. doi:10.1080/10715760701684809

Mrowietz, Christophers, & Altmeyer. (1998). Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. British Journal of Dermatology, 138(3), 456-460. doi:10.1046/j.1365-2133.1998.02124.x

Mrowietz, U., Szepietowski, J. C., Loewe, R., van de Kerkhof, P., Lamarca, R., Ocker, W. G., … Pau-Charles, I. (2016). Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE). British Journal of Dermatology, 176(3), 615-623. doi:10.1111/bjd.14947

Na, L.-X., Li, Y., Pan, H.-Z., Zhou, X.-L., Sun, D.-J., Meng, M., … Sun, C.-H. (2012). Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Molecular Nutrition & Food Research, 57(9), 1569-1577. doi:10.1002/mnfr.201200131

Napetschnig, J., & Wu, H. (2013). Molecular Basis of NF-κB Signaling. Annual Review of Biophysics, 42(1), 443-468. doi:10.1146/annurev-biophys-083012-130338

Nasiri, H. R., Linge, S., & Ullmann, D. (2016). Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactions. Bioorganic & Medicinal Chemistry Letters, 26(2), 526-529. doi:10.1016/j.bmcl.2015.11.082

Natarajan, V. T., Singh, A., Kumar, A. A., Sharma, P., Kar, H. K., Marrot, L., … Gokhale, R. S. (2010). Transcriptional Upregulation of Nrf2-Dependent Phase II Detoxification Genes in the Involved Epidermis of Vitiligo Vulgaris. Journal of Investigative Dermatology, 130(12), 2781-2789. doi:10.1038/jid.2010.201

Nef, H. M., Möllmann, H., Troidl, C., Kostin, S., Böttger, T., Voss, S., … Elsässer, A. (2008). Expression profiling of cardiac genes in Tako-Tsubo cardiomyopathy: Insight into a new cardiac entity. Journal of Molecular and Cellular Cardiology, 44(2), 395-404. doi:10.1016/j.yjmcc.2007.10.015

Nesti, L., & Natali, A. (2017). Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data. Nutrition, Metabolism and Cardiovascular Diseases, 27(8), 657-669. doi:10.1016/j.numecd.2017.04.009

Ockenfels, Schultewolter, Ockenfels, Funk, & Goos. (1998). The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. British Journal of Dermatology, 139(3), 390-395. doi:10.1046/j.1365-2133.1998.02400.x

Okano, Y., Nezu, U., Enokida, Y., Lee, M. T. M., Kinoshita, H., Lezhava, A., … Ishikawa, T. (2013). SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women. PLoS ONE, 8(9), e73794. doi:10.1371/journal.pone.0073794

Olayanju, A., Copple, I. M., Bryan, H. K., Edge, G. T., Sison, R. L., Wong, M. W., … Park, B. K. (2015). Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2. Free Radical Biology and Medicine, 78, 202-212. doi:10.1016/j.freeradbiomed.2014.11.003

Onderdijk, A. J., Balak, D. M. W., Baerveldt, E. M., Florencia, E. F., Kant, M., Laman, J. D., … Prens, E. P. (2014). Regulated genes in psoriatic skin during treatment with fumaric acid esters. British Journal of Dermatology, 171(4), 732-741. doi:10.1111/bjd.13128

Onyiah, J. C., Sheikh, S. Z., Maharshak, N., Otterbein, L. E., & Plevy, S. E. (2013). Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota. Gut Microbes, 5(2), 220-224. doi:10.4161/gmic.27290

Orena, S., Owen, J., Jin, F., Fabian, M., Gillitt, N. D., & Zeisel, S. H. (2015). Extracts of Fruits and Vegetables Activate the Antioxidant Response Element in IMR-32 Cells. The Journal of Nutrition, 145(9), 2006-2011. doi:10.3945/jn.115.216705

OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal, 348(3), 607-614. doi:10.1042/bj3480607

Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., … Yamamoto, M. (2006). Structural Basis for Defects of Keap1 Activity Provoked by Its Point Mutations in Lung Cancer. Molecular Cell, 21(5), 689-700. doi:10.1016/j.molcel.2006.01.013

Pajares, M., Cuadrado, A., & Rojo, A. I. (2017). Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases. Redox Biology, 11, 543-553. doi:10.1016/j.redox.2017.01.006

Pajares, M., Jiménez-Moreno, N., Dias, I. H. K., Debelec, B., Vucetic, M., Fladmark, K. E., … Cuadrado, A. (2015). Redox control of protein degradation. Redox Biology, 6, 409-420. doi:10.1016/j.redox.2015.07.003

Pajares, M., Jiménez-Moreno, N., García-Yagüe, Á. J., Escoll, M., de Ceballos, M. L., Van Leuven, F., … Cuadrado, A. (2016). Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy, 12(10), 1902-1916. doi:10.1080/15548627.2016.1208889

Palomo, V., & Martinez, A. (2016). Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). Expert Opinion on Therapeutic Patents, 27(6), 657-666. doi:10.1080/13543776.2017.1259412

Panieri, E., & Santoro, M. M. (2016). ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death & Disease, 7(6), e2253-e2253. doi:10.1038/cddis.2016.105

Pantan, R., Tocharus, J., Suksamrarn, A., & Tocharus, C. (2016). Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells. Experimental Cell Research, 342(2), 104-112. doi:10.1016/j.yexcr.2016.02.017

Pareek, T. K., Belkadi, A., Kesavapany, S., Zaremba, A., Loh, S. L., Bai, L., … Letterio, J. J. (2011). Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis. Scientific Reports, 1(1). doi:10.1038/srep00201

Park, S. Y., Lee, S. W., Shin, H. K., Chung, W. T., Lee, W. S., Rhim, B. Y., … Kim, C. D. (2010). Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction. Arthritis & Rheumatism, 62(3), 732-741. doi:10.1002/art.27291

Pedruzzi, L. M., Cardozo, L. F. M. F., Daleprane, J. B., Stockler-Pinto, M. B., Monteiro, E. B., Leite, M., … Mafra, D. (2015). Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2. Journal of Nephrology, 28(4), 495-501. doi:10.1007/s40620-014-0162-0

Peng, H., Guerau-de-Arellano, M., Mehta, V. B., Yang, Y., Huss, D. J., Papenfuss, T. L., … Racke, M. K. (2012). Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling. Journal of Biological Chemistry, 287(33), 28017-28026. doi:10.1074/jbc.m112.383380

Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., … Warnock, D. G. (2011). Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes. New England Journal of Medicine, 365(4), 327-336. doi:10.1056/nejmoa1105351

Pilar Valdecantos, M., Prieto-Hontoria, P. L., Pardo, V., Módol, T., Santamaría, B., Weber, M., … Valverde, Á. M. (2015). Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. Free Radical Biology and Medicine, 84, 263-278. doi:10.1016/j.freeradbiomed.2015.03.019

Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., … Furlong, L. I. (2016). DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Research, 45(D1), D833-D839. doi:10.1093/nar/gkw943

Pitha-Rowe, I., Liby, K., Royce, D., & Sporn, M. (2009). Synthetic Triterpenoids Attenuate Cytotoxic Retinal Injury: Cross-talk between Nrf2 and PI3K/AKT Signaling through Inhibition of the Lipid Phosphatase PTEN. Investigative Opthalmology & Visual Science, 50(11), 5339. doi:10.1167/iovs.09-3648

Qiu, P., Man, S., Li, J., Liu, J., Zhang, L., Yu, P., & Gao, W. (2016). Overdose Intake of Curcumin Initiates the Unbalanced State of Bodies. Journal of Agricultural and Food Chemistry, 64(13), 2765-2771. doi:10.1021/acs.jafc.6b00053

Rachakonda, G., Xiong, Y., Sekhar, K. R., Stamer, S. L., Liebler, D. C., & Freeman, M. L. (2008). Covalent Modification at Cys151 Dissociates the Electrophile Sensor Keap1 from the Ubiquitin Ligase CUL3. Chemical Research in Toxicology, 21(3), 705-710. doi:10.1021/tx700302s

Rada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A. (2011). SCF/ -TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner. Molecular and Cellular Biology, 31(6), 1121-1133. doi:10.1128/mcb.01204-10

Rada, P., Rojo, A. I., Evrard-Todeschi, N., Innamorato, N. G., Cotte, A., Jaworski, T., … Cuadrado, A. (2012). Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/ -TrCP Axis. Molecular and Cellular Biology, 32(17), 3486-3499. doi:10.1128/mcb.00180-12

Ramadori, P., Drescher, H., Erschfeld, S., Schumacher, F., Berger, C., Fragoulis, A., … Streetz, K. L. (2016). Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development. Free Radical Biology and Medicine, 91, 114-126. doi:10.1016/j.freeradbiomed.2015.12.014

Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., … Jordan-Sciutto, K. L. (2007). Expression of Nrf2 in Neurodegenerative Diseases. Journal of Neuropathology and Experimental Neurology, 66(1), 75-85. doi:10.1097/nen.0b013e31802d6da9

Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., … Biswal, S. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice. Journal of Clinical Investigation, 114(9), 1248-1259. doi:10.1172/jci200421146

Ranjan, N., Fulcrand, G., King, A., Brown, J., Jiang, X., Leng, F., & Arya, D. P. (2014). Selective inhibition of bacterial topoisomerase I by alkynyl-bisbenzimidazoles. Med. Chem. Commun., 5(6), 816-825. doi:10.1039/c4md00140k

Reccia, I., Kumar, J., Akladios, C., Virdis, F., Pai, M., Habib, N., & Spalding, D. (2017). Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism, 72, 94-108. doi:10.1016/j.metabol.2017.04.011

Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011). Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proceedings of the National Academy of Sciences, 108(4), 1433-1438. doi:10.1073/pnas.1014275108

Rena, G., Hardie, D. G., & Pearson, E. R. (2017). The mechanisms of action of metformin. Diabetologia, 60(9), 1577-1585. doi:10.1007/s00125-017-4342-z

Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology and Medicine, 49(11), 1603-1616. doi:10.1016/j.freeradbiomed.2010.09.006

Richardson, B. G., Jain, A. D., Speltz, T. E., & Moore, T. W. (2015). Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway. Bioorganic & Medicinal Chemistry Letters, 25(11), 2261-2268. doi:10.1016/j.bmcl.2015.04.019

Roberts, C. A., Dickinson, A. K., & Taams, L. S. (2015). The Interplay Between Monocytes/Macrophages and CD4+ T Cell Subsets in Rheumatoid Arthritis. Frontiers in Immunology, 6. doi:10.3389/fimmu.2015.00571

Rojo, A. I., Innamorato, N. G., Martín-Moreno, A. M., De Ceballos, M. L., Yamamoto, M., & Cuadrado, A. (2009). Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson’s disease. Glia, 58(5), 588-598. doi:10.1002/glia.20947

Rojo, A. I., McBean, G., Cindric, M., Egea, J., López, M. G., Rada, P., … Cuadrado, A. (2014). Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance. Antioxidants & Redox Signaling, 21(12), 1766-1801. doi:10.1089/ars.2013.5745

Rojo, A. I., Rada, P., Mendiola, M., Ortega-Molina, A., Wojdyla, K., Rogowska-Wrzesinska, A., … Cuadrado, A. (2014). The PTEN/NRF2 Axis Promotes Human Carcinogenesis. Antioxidants & Redox Signaling, 21(18), 2498-2514. doi:10.1089/ars.2014.5843

Rushworth, S. A., Zaitseva, L., Murray, M. Y., Shah, N. M., Bowles, K. M., & MacEwan, D. J. (2012). The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. Blood, 120(26), 5188-5198. doi:10.1182/blood-2012-04-422121

Ryoo, I., Lee, S., & Kwak, M.-K. (2016). Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance. Oxidative Medicine and Cellular Longevity, 2016, 1-14. doi:10.1155/2016/2428153

Saddawi-Konefka, R., Seelige, R., Gross, E. T. E., Levy, E., Searles, S. C., Washington, A., … Bui, J. D. (2016). Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance. Cell Reports, 16(9), 2348-2358. doi:10.1016/j.celrep.2016.07.075

Saracino, A. M., & Orteu, C. H. (2016). Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters. British Journal of Dermatology, 176(2), 472-480. doi:10.1111/bjd.14698

Sato M Aoki T Inoue H Tanaka T Kunishima N (2013) Keap1 Protein Binding Compound, Cristal of Complex Between the Same and Keap1 Protein, and Method for Producing the Same, Toray Industries, Tokyo.

Sato, N., Takasaka, N., Yoshida, M., Tsubouchi, K., Minagawa, S., Araya, J., … Kuwano, K. (2016). Metformin attenuates lung fibrosis development via NOX4 suppression. Respiratory Research, 17(1). doi:10.1186/s12931-016-0420-x

Satoh, T., McKercher, S. R., & Lipton, S. A. (2013). Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radical Biology and Medicine, 65, 645-657. doi:10.1016/j.freeradbiomed.2013.07.022

Scannevin, R. H., Chollate, S., Jung, M., Shackett, M., Patel, H., Bista, P., … Rhodes, K. J. (2012). Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway. Journal of Pharmacology and Experimental Therapeutics, 341(1), 274-284. doi:10.1124/jpet.111.190132

Schilling, S., Goelz, S., Linker, R., Luehder, F., & Gold, R. (2006). Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clinical and Experimental Immunology, 145(1), 101-107. doi:10.1111/j.1365-2249.2006.03094.x

Schimrigk, S., Brune, N., Hellwig, K., Lukas, C., Bellenberg, B., Rieks, M., … Przuntek, H. (2006). Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. European Journal of Neurology, 13(6), 604-610. doi:10.1111/j.1468-1331.2006.01292.x

Schipper, H. M., Song, W., Zukor, H., Hascalovici, J. R., & Zeligman, D. (2009). Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. Journal of Neurochemistry, 110(2), 469-485. doi:10.1111/j.1471-4159.2009.06160.x

Schuiveling M Vazirpanah N Radstake TRDJ Zimmermann M Broen JCA (2017) Metformin, a new era for an old drug in the treatment of immune mediated disease? Curr Drug Targets [published ahead of print].

Schulze-Topphoff, U., Varrin-Doyer, M., Pekarek, K., Spencer, C. M., Shetty, A., Sagan, S. A., … Zamvil, S. S. (2016). Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proceedings of the National Academy of Sciences, 113(17), 4777-4782. doi:10.1073/pnas.1603907113

Schumacker, P. T. (2006). Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell, 10(3), 175-176. doi:10.1016/j.ccr.2006.08.015

Sha, L. K., Sha, W., Kuchler, L., Daiber, A., Giegerich, A. K., Weigert, A., … von Knethen, A. (2015). Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8+ T cell function by limiting GSH and Cys availability. Free Radical Biology and Medicine, 83, 77-88. doi:10.1016/j.freeradbiomed.2015.02.004

Shanmugam, G., Narasimhan, M., Conley, R. L., Sairam, T., Kumar, A., Mason, R. P., … Rajasekaran, N. S. (2017). Chronic Endurance Exercise Impairs Cardiac Structure and Function in Middle-Aged Mice with Impaired Nrf2 Signaling. Frontiers in Physiology, 8. doi:10.3389/fphys.2017.00268

Shanmugam, G., Narasimhan, M., Tamowski, S., Darley-Usmar, V., & Rajasekaran, N. S. (2017). Constitutive activation of Nrf2 induces a stable reductive state in the mouse myocardium. Redox Biology, 12, 937-945. doi:10.1016/j.redox.2017.04.038

Sharma, A., Rizky, L., Stefanovic, N., Tate, M., Ritchie, R. H., Ward, K. W., & de Haan, J. B. (2017). The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction. Cardiovascular Diabetology, 16(1). doi:10.1186/s12933-017-0513-y

Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., … Yamamoto, M. (2011). NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer. Neoplasia, 13(9), 864-IN26. doi:10.1593/neo.11750

Shimizu, T., Inoue, K., Hachiya, H., Shibuya, N., Aoki, T., & Kubota, K. (2016). Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 23(8), 467-471. doi:10.1002/jhbp.364

Shimoyama, Y., Mitsuda, Y., Tsuruta, Y., Hamajima, N., & Niwa, T. (2014). Polymorphism of Nrf2, an Antioxidative Gene, is Associated with Blood Pressure and Cardiovascular Mortality in Hemodialysis Patients. International Journal of Medical Sciences, 11(7), 726-731. doi:10.7150/ijms.8590

Shimozono, R., Asaoka, Y., Yoshizawa, Y., Aoki, T., Noda, H., Yamada, M., … Mochizuki, H. (2013). Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model. Molecular Pharmacology, 84(1), 62-70. doi:10.1124/mol.112.084269

Signorelli, S. S., Volsi, G. L., Fiore, V., Mangiafico, M., Barbagallo, I., Parenti, R., … Volti, G. L. (2016). Plasma heme oxygenase-1 is decreased in peripheral artery disease patients. Molecular Medicine Reports, 14(4), 3459-3463. doi:10.3892/mmr.2016.5644

Silva, T., Reis, J., Teixeira, J., & Borges, F. (2014). Alzheimer’s disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes. Ageing Research Reviews, 15, 116-145. doi:10.1016/j.arr.2014.03.008

Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., … Biswal, S. (2006). Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer. PLoS Medicine, 3(10), e420. doi:10.1371/journal.pmed.0030420

Singh, A., Venkannagari, S., Oh, K. H., Zhang, Y.-Q., Rohde, J. M., Liu, L., … Biswal, S. (2016). Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. ACS Chemical Biology, 11(11), 3214-3225. doi:10.1021/acschembio.6b00651

Siomek, A. (2012). NF-κB signaling pathway and free radical impact. Acta Biochimica Polonica, 59(3). doi:10.18388/abp.2012_2116

Song, P., Li, K., Liu, L., Wang, X., Jian, Z., Zhang, W., … Gao, T. (2016). Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations. Journal of Cellular and Molecular Medicine, 20(10), 1840-1850. doi:10.1111/jcmm.12874

Stocker, R., Yamamoto, Y., McDonagh, A., Glazer, A., & Ames, B. (1987). Bilirubin is an antioxidant of possible physiological importance. Science, 235(4792), 1043-1046. doi:10.1126/science.3029864

Strom, J., & Chen, Q. M. (2017). Loss of Nrf2 promotes rapid progression to heart failure following myocardial infarction. Toxicology and Applied Pharmacology, 327, 52-58. doi:10.1016/j.taap.2017.03.025

Sun, H., Zhu, J., Lin, H., Gu, K., & Feng, F. (2017). Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016). Expert Opinion on Therapeutic Patents, 27(7), 763-785. doi:10.1080/13543776.2017.1325464

Taguchi, K., & Yamamoto, M. (2017). The KEAP1–NRF2 System in Cancer. Frontiers in Oncology, 7. doi:10.3389/fonc.2017.00085

Tahvili, S., Zandieh, B., & Amirghofran, Z. (2015). The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis. International Journal of Dermatology, 54(7), e254-e260. doi:10.1111/ijd.12834

Takahashi, Y., Kobayashi, Y., Kawata, K., Kawamura, K., Sumiyoshi, S., Noritake, H., … Suda, T. (2014). Does Hepatic Oxidative Stress Enhance Activation of Nuclear Factor-E2-Related Factor in Patients with Nonalcoholic Steatohepatitis? Antioxidants & Redox Signaling, 20(3), 538-543. doi:10.1089/ars.2013.5470

Tan, S. M., Sharma, A., Stefanovic, N., Yuen, D. Y. C., Karagiannis, T. C., Meyer, C., … de Haan, J. B. (2014). Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease. Diabetes, 63(9), 3091-3103. doi:10.2337/db13-1743

Tang, X., Lin, C.-C., Spasojevic, I., Iversen, E. S., Chi, J.-T., & Marks, J. R. (2014). A joint analysis of metabolomics and genetics of breast cancer. Breast Cancer Research, 16(4). doi:10.1186/s13058-014-0415-9

Tarumoto, T., Nagai, T., Ohmine, K., Miyoshi, T., Nakamura, M., Kondo, T., … Ozawa, K. (2004). Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line. Experimental Hematology, 32(4), 375-381. doi:10.1016/j.exphem.2004.01.007

Thimmulappa, R. K. (2006). Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. Journal of Clinical Investigation, 116(4), 984-995. doi:10.1172/jci25790

Thimmulappa, R. K., Scollick, C., Traore, K., Yates, M., Trush, M. A., Liby, K. T., … Biswal, S. (2006). Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochemical and Biophysical Research Communications, 351(4), 883-889. doi:10.1016/j.bbrc.2006.10.102

Thomson, L., Tenopoulou, M., Lightfoot, R., Tsika, E., Parastatidis, I., Martinez, M., … Ischiropoulos, H. (2012). Immunoglobulins Against Tyrosine-Nitrated Epitopes in Coronary Artery Disease. Circulation, 126(20), 2392-2401. doi:10.1161/circulationaha.112.103796

Todorovic, M., Newman, J. R. B., Shan, J., Bentley, S., Wood, S. A., Silburn, P. A., & Mellick, G. D. (2015). Comprehensive Assessment of Genetic Sequence Variants in the Antioxidant ‘Master Regulator’ Nrf2 in Idiopathic Parkinson’s Disease. PLOS ONE, 10(5), e0128030. doi:10.1371/journal.pone.0128030

Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. (2007). Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response. Molecular and Cellular Biology, 27(21), 7511-7521. doi:10.1128/mcb.00753-07

Tsai, H.-H., Lai, H.-Y., Chen, Y.-C., Li, C.-F., Huang, H.-S., Liu, H.-S., … Wang, J.-M. (2017). Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway. Oncotarget, 8(8), 13832-13845. doi:10.18632/oncotarget.14640

Tsuchida, K., Tsujita, T., Hayashi, M., Ojima, A., Keleku-Lukwete, N., Katsuoka, F., … Yamamoto, M. (2017). Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation. Free Radical Biology and Medicine, 103, 236-247. doi:10.1016/j.freeradbiomed.2016.12.041

Tu, J., Zhang, X., Zhu, Y., Dai, Y., Li, N., Yang, F., … Wang, R. (2015). Cell-Permeable Peptide Targeting the Nrf2-Keap1 Interaction: A Potential Novel Therapy for Global Cerebral Ischemia. Journal of Neuroscience, 35(44), 14727-14739. doi:10.1523/jneurosci.1304-15.2015

Tung, M.-C., Lin, P.-L., Wang, Y.-C., He, T.-Y., Lee, M.-C., Yeh, S.-D., … Lee, H. (2015). Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2. Oncotarget, 6(39), 41692-41705. doi:10.18632/oncotarget.6150

Türei, D., Papp, D., Fazekas, D., Földvári-Nagy, L., Módos, D., Lenti, K., … Korcsmáros, T. (2013). NRF2-ome: An Integrated Web Resource to Discover Protein Interaction and Regulatory Networks of NRF2. Oxidative Medicine and Cellular Longevity, 2013, 1-9. doi:10.1155/2013/737591

Tzima, S., Victoratos, P., Kranidioti, K., Alexiou, M., & Kollias, G. (2009). Myeloid heme oxygenase–1 regulates innate immunity and autoimmunity by modulating IFN-β production. Journal of Experimental Medicine, 206(5), 1167-1179. doi:10.1084/jem.20081582

Ungvari, Z., Bagi, Z., Feher, A., Recchia, F. A., Sonntag, W. E., Pearson, K., … Csiszar, A. (2010). Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. American Journal of Physiology-Heart and Circulatory Physiology, 299(1), H18-H24. doi:10.1152/ajpheart.00260.2010

Ungvari, Z., Bailey-Downs, L., Gautam, T., Jimenez, R., Losonczy, G., Zhang, C., … Csiszar, A. (2011). Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. American Journal of Physiology-Heart and Circulatory Physiology, 300(4), H1133-H1140. doi:10.1152/ajpheart.00402.2010

Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., … Yamamoto, M. (2013). The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus. Molecular and Cellular Biology, 33(15), 2996-3010. doi:10.1128/mcb.00225-13

Uruno, A., Yagishita, Y., & Yamamoto, M. (2015). The Keap1–Nrf2 system and diabetes mellitus. Archives of Biochemistry and Biophysics, 566, 76-84. doi:10.1016/j.abb.2014.12.012

Van Horssen, J., Drexhage, J. A. R., Flor, T., Gerritsen, W., van der Valk, P., & de Vries, H. E. (2010). Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radical Biology and Medicine, 49(8), 1283-1289. doi:10.1016/j.freeradbiomed.2010.07.013

Van Muiswinkel, F. ., de Vos, R. A. ., Bol, J. G. J. ., Andringa, G., Jansen Steur, E. N. ., Ross, D., … Drukarch, B. (2004). Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra. Neurobiology of Aging, 25(9), 1253-1262. doi:10.1016/j.neurobiolaging.2003.12.010

Vidal, M., Cusick, M. E., & Barabási, A.-L. (2011). Interactome Networks and Human Disease. Cell, 144(6), 986-998. doi:10.1016/j.cell.2011.02.016

Von Otter, M., Bergström, P., Quattrone, A., De Marco, E. V., Annesi, G., Söderkvist, P., … Zetterberg, H. (2014). Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study. BMC Medical Genetics, 15(1). doi:10.1186/s12881-014-0131-4

Von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A., … Zetterberg, H. (2010). Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson’s disease. BMC Medical Genetics, 11(1). doi:10.1186/1471-2350-11-36

Von Otter, M., Landgren, S., Nilsson, S., Zetterberg, M., Celojevic, D., Bergström, P., … Zetterberg, H. (2010). Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer’s disease and age-related cataract. Mechanisms of Ageing and Development, 131(2), 105-110. doi:10.1016/j.mad.2009.12.007

Wang, L., Han, J., Shan, P., You, S., Chen, X., Jin, Y., … Liang, G. (2017). MD2 Blockage Protects Obesity-Induced Vascular Remodeling via Activating AMPK/Nrf2. Obesity, 25(9), 1532-1539. doi:10.1002/oby.21916

Wang, R., An, J., Ji, F., Jiao, H., Sun, H., & Zhou, D. (2008). Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochemical and Biophysical Research Communications, 373(1), 151-154. doi:10.1016/j.bbrc.2008.06.004

Wang, X., Chen, H., Liu, J., Ouyang, Y., Wang, D., Bao, W., & Liu, L. (2015). Association between the NF-E2 Related Factor 2 Gene Polymorphism and Oxidative Stress, Anti-Oxidative Status, and Newly-Diagnosed Type 2 Diabetes Mellitus in a Chinese Population. International Journal of Molecular Sciences, 16(7), 16483-16496. doi:10.3390/ijms160716483

Wang, X., de Rivero Vaccari, J. P., Wang, H., Diaz, P., German, R., Marcillo, A. E., & Keane, R. W. (2012). Activation of the Nuclear Factor E2-Related Factor 2/Antioxidant Response Element Pathway Is Neuroprotective after Spinal Cord Injury. Journal of Neurotrauma, 29(5), 936-945. doi:10.1089/neu.2011.1922

Wang, X., Hausding, M., Weng, S.-Y., Kim, Y. O., Steven, S., Klein, T., … Schuppan, D. (2018). Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis. Antioxidants & Redox Signaling, 28(2), 87-109. doi:10.1089/ars.2016.6953

Wang, X., Li, M., Cao, Y., Wang, J., Zhang, H., Zhou, X., … Wang, L. (2017). Tenuigenin inhibits LPS-induced inflammatory responses in microglia via activating the Nrf2-mediated HO-1 signaling pathway. European Journal of Pharmacology, 809, 196-202. doi:10.1016/j.ejphar.2017.05.004

Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007). Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha. Proceedings of the National Academy of Sciences, 104(49), 19589-19594. doi:10.1073/pnas.0709483104

Wang, Y., Huang, Y., Xu, Y., Ruan, W., Wang, H., Zhang, Y., … Pang, T. (2018). A Dual AMPK/Nrf2 Activator Reduces Brain Inflammation After Stroke by Enhancing Microglia M2 Polarization. Antioxidants & Redox Signaling, 28(2), 141-163. doi:10.1089/ars.2017.7003

Wasik, U., Milkiewicz, M., Kempinska-Podhorodecka, A., & Milkiewicz, P. (2017). Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis. Scientific Reports, 7(1). doi:10.1038/srep44769

Wen, X., Thorne, G., Hu, L., Joy, M. S., & Aleksunes, L. M. (2015). Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor. Journal of Biochemical and Molecular Toxicology, 29(6), 261-266. doi:10.1002/jbt.21693

Wenzel, P., Kossmann, S., Münzel, T., & Daiber, A. (2017). Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species. Free Radical Biology and Medicine, 109, 48-60. doi:10.1016/j.freeradbiomed.2017.01.027

Wenzel, P., Oelze, M., Coldewey, M., Hortmann, M., Seeling, A., Hink, U., … Daiber, A. (2007). Heme Oxygenase-1. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(8), 1729-1735. doi:10.1161/atvbaha.107.143909

Wenzel, P., Rossmann, H., Müller, C., Kossmann, S., Oelze, M., Schulz, A., … Münzel, T. (2015). Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. European Heart Journal, 36(48), 3437-3446. doi:10.1093/eurheartj/ehv544

Winkel, A. F., Engel, C. K., Margerie, D., Kannt, A., Szillat, H., Glombik, H., … Schmoll, D. (2015). Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling. Journal of Biological Chemistry, 290(47), 28446-28455. doi:10.1074/jbc.m115.678136

Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999). The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro. Genes & Development, 13(3), 270-283. doi:10.1101/gad.13.3.270

Wu, Q., Wang, Q., Mao, G., Dowling, C. A., Lundy, S. K., & Mao-Draayer, Y. (2017). Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. The Journal of Immunology, 198(8), 3069-3080. doi:10.4049/jimmunol.1601532

Wu, W., Zhao, L., Yang, P., Zhou, W., Li, B., Moorhead, J. F., … Chen, Y. (2016). Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice. PLOS ONE, 11(7), e0159512. doi:10.1371/journal.pone.0159512

Wu, W.-J., Jia, W.-W., Liu, X.-H., Pan, L.-L., Zhang, Q.-Y., Yang, D., … Zhu, Y. Z. (2016). S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway. Redox Biology, 10, 157-167. doi:10.1016/j.redox.2016.08.011

Xia, N., Daiber, A., Förstermann, U., & Li, H. (2016). Antioxidant effects of resveratrol in the cardiovascular system. British Journal of Pharmacology, 174(12), 1633-1646. doi:10.1111/bph.13492

Xiaobo, C., Majidi, M., Feng, M., Shao, R., Wang, J., Zhao, Y., … Roth, J. A. (2016). TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin. Scientific Reports, 6(1). doi:10.1038/srep35741

Xie, H., Zhou, F., Liu, L., Zhu, G., Li, Q., Li, C., & Gao, T. (2016). Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity? Journal of Dermatological Science, 81(1), 3-9. doi:10.1016/j.jdermsci.2015.09.003

Xiong, M., Li, B., Zhu, Q., Wang, Y.-X., & Zhang, H.-Y. (2013). Identification of transcription factors for drug-associated gene modules and biomedical implications. Bioinformatics, 30(3), 305-309. doi:10.1093/bioinformatics/btt683

Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., … Ng, I. O.-L. (2016). Transketolase counteracts oxidative stress to drive cancer development. Proceedings of the National Academy of Sciences, 113(6), E725-E734. doi:10.1073/pnas.1508779113

Xu, J., Donepudi, A. C., Moscovitz, J. E., & Slitt, A. L. (2013). Keap1-Knockdown Decreases Fasting-Induced Fatty Liver via Altered Lipid Metabolism and Decreased Fatty Acid Mobilization from Adipose Tissue. PLoS ONE, 8(11), e79841. doi:10.1371/journal.pone.0079841

Xu, X., Sun, J., Chang, X., Wang, J., Luo, M., Wintergerst, K. A., … Cai, L. (2016). Genetic variants of nuclear factor erythroid‐derived 2‐like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China. Journal of Cellular and Molecular Medicine, 20(11), 2078-2088. doi:10.1111/jcmm.12900

Xu, Z., Wei, Y., Gong, J., Cho, H., Park, J. K., Sung, E.-R., … Duh, E. J. (2013). NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia, 57(1), 204-213. doi:10.1007/s00125-013-3093-8

Xu, Z., Zhang, F., Sun, F., Gu, K., Dong, S., & He, D. (2014). Dimethyl fumarate for multiple sclerosis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011076

Xue, P., Hou, Y., Chen, Y., Yang, B., Fu, J., Zheng, H., … Pi, J. (2012). Adipose Deficiency of Nrf2 in ob/ob Mice Results in Severe Metabolic Syndrome. Diabetes, 62(3), 845-854. doi:10.2337/db12-0584

Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H., & Yamamoto, M. (2008). Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity. Molecular and Cellular Biology, 28(8), 2758-2770. doi:10.1128/mcb.01704-07

Yamamoto, T., Yoh, K., Kobayashi, A., Ishii, Y., Kure, S., Koyama, A., … Yamamoto, M. (2004). Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochemical and Biophysical Research Communications, 321(1), 72-79. doi:10.1016/j.bbrc.2004.06.112

Yang, M., Yao, Y., Eades, G., Zhang, Y., & Zhou, Q. (2011). MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Research and Treatment, 129(3), 983-991. doi:10.1007/s10549-011-1604-1

Yao, W., Zhang, J., Ishima, T., Dong, C., Yang, C., Ren, Q., … Hashimoto, K. (2016). Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice. Scientific Reports, 6(1). doi:10.1038/srep30659

Yap, J. L., Worlikar, S., MacKerell, A. D., Shapiro, P., & Fletcher, S. (2010). Small-Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics. ChemMedChem, 6(1), 38-48. doi:10.1002/cmdc.201000354

Yoh, K., Hirayama, A., Ishizaki, K., Yamada, A., Takeuchi, M., Yamagishi, S., … Yamamoto, M. (2008). Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes to Cells. doi:10.1111/j.1365-2443.2008.01234.x

Yore, M. M., Kettenbach, A. N., Sporn, M. B., Gerber, S. A., & Liby, K. T. (2011). Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR. PLoS ONE, 6(7), e22862. doi:10.1371/journal.pone.0022862

Yoshizaki, Y., Mori, T., Ishigami-Yuasa, M., Kikuchi, E., Takahashi, D., Zeniya, M., … Sohara, E. (2017). Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy. Scientific Reports, 7(1). doi:10.1038/s41598-017-04233-3

Yu, M., Li, H., Liu, Q., Liu, F., Tang, L., Li, C., … Yang, X. (2011). Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cellular Signalling, 23(5), 883-892. doi:10.1016/j.cellsig.2011.01.014

Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., … Devlin, S. M. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713. doi:10.1038/nm.4333

Zeidan TA Duncan S Hencken CP Wynn TA Sanrame CN (2014) Prodrugs of Fumarates and Their Use in Treating Various Diseases, Alkermes Pharma Ireland, Dublin, Ireland.

Zhang, D. D. (2013). Bardoxolone Brings Nrf2-Based Therapies to Light. Antioxidants & Redox Signaling, 19(5), 517-518. doi:10.1089/ars.2012.5118

Zhao, C., Zhang, Y., Liu, H., Li, P., Zhang, H., & Cheng, G. (2017). Fortunellin protects against high fructose-induced diabetic heart injury in mice by suppressing inflammation and oxidative stress via AMPK/Nrf-2 pathway regulation. Biochemical and Biophysical Research Communications, 490(2), 552-559. doi:10.1016/j.bbrc.2017.06.076

Zhao, M., Chen, H., Ding, Q., Xu, X., Yu, B., & Huang, Z. (2016). Nuclear Factor Erythroid 2-related Factor 2 Deficiency Exacerbates Lupus Nephritis in B6/lpr mice by Regulating Th17 Cell Function. Scientific Reports, 6(1). doi:10.1038/srep38619

Zhou, X., Menche, J., Barabási, A.-L., & Sharma, A. (2014). Human symptoms–disease network. Nature Communications, 5(1). doi:10.1038/ncomms5212




This item appears in the following Collection(s)

Show full item record